Replimune has assembled a world-class team who together pioneered the development of the first FDA-approved oncolytic immunotherapy. Replimune is pioneering a new generation of cancer treatments called oncolytic immunotherapies. These cleverly designed therapeutics combine multiple mechanisms of action, enhancing the ability of viruses to replicate in and kill cancer cells, and generating a powerful patient-specific, systemic ...
Replimune has assembled a world-class team who together pioneered the development of the first FDA-approved oncolytic immunotherapy. Replimune is pioneering a new generation of cancer treatments called oncolytic immunotherapies. These cleverly designed therapeutics combine multiple mechanisms of action, enhancing the ability of viruses to replicate in and kill cancer cells, and generating a powerful patient-specific, systemic anti-tumor immune response.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.